ViewPoint Therapeutics, Inc.
Biotechnology company · San Francisco, California, United States
ViewPoint Therapeutics, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2014. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $446,978 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $21 million sold in a notice filed in 2018.
ViewPoint Therapeutics at a glance
What does ViewPoint Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $446,978 in total (2016 to 2020). NIH funding came from the National Eye Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $20.9 million sold (2018).
Frequently asked questions about ViewPoint Therapeutics
Where is ViewPoint Therapeutics headquartered?
ViewPoint Therapeutics, Inc. is headquartered in San Francisco, California, United States.
What does ViewPoint Therapeutics do?
ViewPoint Therapeutics, Inc. is a biotechnology company.
When was ViewPoint Therapeutics founded?
The earliest incorporation on record for ViewPoint Therapeutics, Inc. is in 2014, according to public company registers.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences